Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Second-generation Sequencing in the Treatment of Severe Pneumonia With Initial Treatment Failure

NCT03884881 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT03884881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Second-generation Sequencing in the Treatment of Severe Pneumonia With Initial Treatment Failure
Lead sponsor
Xiangya Hospital of Central South University
Phase
Not applicable
Overall status
Unknown status
Start date
January 1, 2018
Completion date
December 1, 2019
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metagenomic next generation sequencing, pneumonia